Skip to content

Systematic Review of Phenotypical Characteristics of P51S COCH Mutation

Systematic Review of Phenotype Characteristics of DFNA9 Caused by the Pro51 Ser (P51S) Mutation in COCH

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03707756
Enrollment
0
Registered
2018-10-16
Start date
2018-05-01
Completion date
2018-09-30
Last updated
2018-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DFNA9

Keywords

DFNA9, COCh, Mutation, Genotype-phenotype

Brief summary

Gene mutations account for more than 60% of congenital sensorineural hearing loss (SNHL) in Western Countries. Hereditary SNHL does not necessarily start at birth, however, as many causative gene mutations only begin to express at much later ages, such as for example DFNA9, also known as the ninth discovered autosomal dominant SNHL. It is characterized by a late onset of rapid progressive SNHL together with accompanying vestibular impairment. The first reported DFNA9 patients were carrying the c.151 C\>T mutation in COCH, which is the result of a substitution of cytosine by thymine nucleotide of the 151th base pair (c.151C\>T). At protein level, this missense point mutation induces a mistranslation to a serine instead of a proline amino-acid (p.Pro51Ser, (P51S)), producing mutant cochlin that cause a dominant negative effect due to misfolding. In the perspective of promising future hearing and vestibular treatment developments, such as gene therapy, stem cell therapy, neural regeneration, in association with cochlear and/or vestibular implantation, a more accurate understanding of the onset of the very first signs of the auditory and vestibular deterioration is important. However, in early stages these first signs of impairment are very discrete and pre-symptomatic. The aim of this systematic review is to identify studies related to DFNA9, caused by the P51S COCH variant, describing detailed genotype-phenotype correlation in relation to the age and to investigate the age of onset of the SNHL and peripheral vestibular function as well as their progression in relation to age.

Detailed description

The strategy and methodology used for the systematic review was based on the PRISMA Statement (Preferred Reporting Items for Systematic Reviews and Meta-Analysis Medline, PubMed, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, ISI Web of Knowledge and Web of Science were searched. Information was retrieved about COCH mutations causing DFNA9, including phenotype, genotype, audiometric and vestibular data. Audiometric data were collected using individual measurements or pure tone average incides in the selected records.In case of different audiometric data presentation, for instance audiograms or different pure tone average (PTA) plots against age, a comprehensive assessment and inventory of all individual measurements was conducted. All available measurements at both ears per frequency were inventoried and a binaural mean value for each frequency per age was averaged, before the calculation of the indices. If longitudinal measurements of the same individual were shown, all the available data was included in the assessment. The following parameters for the audiometric data were inventoried: pure tone average (PTA), Annual Threshold detarioration (ATD) per frequency and/or PTA, Age-related Typical Audiogram (ARTA) and age of onset of the sensorineural hearing loss (SNHL). For the vestibular function, all different parameters of the vestibular function were inventoried. Normative values, if mentioned, were used to evaluate the measurements. An overall inventory of all individual vestibular measurements in relation to age was conducted. The following parameters for the vestibular function were inventoried: Time Constant (T) derived from velocity-step test (VST) in seconds, Caloric response gain on electronystagmography, Annual vestibular deterioration rate and age of onset of vestibular dysfunction.

Interventions

None listed

Sponsors

Jessa Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* P51S carriership

Exclusion criteria

* no P51S carriership

Design outcomes

Primary

MeasureTime frameDescription
age of onset sensorineural hearing loss10 yearsAge of onset sensorineural hearing loss (years) in P51S COCH mutation carriers
annual threshold deterioration10 yearsAnnual threshold deterioration (decibel hearing loss per year) in P51S COCH mutation carriers
age of onset vestibular dysfunction10 yearsAge of onset vestibular dysfunction (time constant T (seconds) in P51S COCH mutation carriers
annual vestibular deterioration rate10 yearsAnnual vestibular deterioration (seconds per year) in P51S COCH mutation carriers
Pure Tone Average (PTA)10 yearsPure tone average (PTA) in decibel hearing loss (dB HL) of P51S COCH mutations carriers
Age-Related Typical Audiogram (ARTA)10 yearsAge-related typical audiogram (ARTA) of P51S COCH mutation carriers
Time Constant 'T'10 yearsTime constant 'T' with velocity-step test(VST) (seconds) in P51S COCH mutation carriers
gain of caloric test of ENG10 yearssummation of gain in caloric test of electronystagmography (ENG) (degrees per second) of P51S COCH mutation carriers

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026